Related Experiment Video
Updated: Jul 27, 2025

Neural Tube Closure in Mouse Whole Embryo Culture
Published on: October 21, 2011
MALFORMATIONS OF THE CENTRAL NERVOUS SYSTEM INDUCED BY NEUROTROPIC DRUGS IN MOUSE EMBRYOS
1University of Edinburgh, Institute of Animal Genetics, West Mains Road, Edinburgh EH 9 3JN, United Kingdom.
Abstract:
Out of a sample of fifteen neurotropic drugs consisting of seven antidepressants and anti-psychotics, two antianxiety drugs, one anticonvulsant, three opiates and two synthetic analgesics, twelve were found to be teratogenic for mouse embryos, causing malformations of the central nervous system. After single injections of the teratogenic dose administered at the very beginning of the ninth day of gestation, four days later, i.e. in 13-day-old embryos, the induced defects appeared to make up a recurring syndrome of malformations which consists of several abnormalities present in various frequencies either individually or in combination in the same embryos. These malformations are: exencephaly, craniorachischisis, cervical and thoraco-lumbar myeloschisis, hydrocephalic dilatation of the fourth brain ventricle, Z-shaped kinking of the spinal cord and lumbar hydromyelia. In addition, after administration of some of the drugs, branchyury or anury with or without lumbar myeloaplasia were recorded. In general the results reported here seem to suggest that because of their possible affinity neurotropic drugs are potentially teratogenic for the embryonic central nervous system if applied at the time of the neural tube closure although it is known that there are drugs in this group which do not cause any malformations of the central nervous system and that many non-neurotropic agents do cause such malformations. Secondly, the results seem to suggest also that the position of the malformations along the cerebro-spinal axis may be depending to some extent on the pharmacological properties of the drugs tested. These conjectures are treated here as entirely provisional pending further investigations.
Insights
Twelve of fifteen neurotropic drugs caused central nervous system malformations in mouse embryos. These neurotropic teratogens, when given during neural tube closure, induced a recurring syndrome of birth defects.
Area of Science:
- Developmental toxicology
- Neuroscience
- Pharmacology
Background:
- Neurotropic drugs, including antidepressants, antipsychotics, and analgesics, are widely used.
- The potential for these drugs to affect embryonic development, particularly the central nervous system (CNS), is a critical concern.
Purpose of the Study:
- To investigate the teratogenic potential of various neurotropic drugs on the developing CNS in mouse embryos.
- To characterize the specific malformations induced by these drugs and explore potential correlations with drug properties.
Main Methods:
- A sample of fifteen neurotropic drugs (antidepressants, antipsychotics, antianxiety, anticonvulsant, opiates, synthetic analgesics) was administered to pregnant mice at the beginning of the ninth day of gestation.
- Embryos (13 days old) were examined for CNS malformations.
Main Results:
- Twelve out of fifteen tested neurotropic drugs were found to be teratogenic, causing significant CNS malformations in mouse embryos.
- A recurring syndrome of malformations was observed, including exencephaly, myeloschisis, hydrocephalus, spinal cord kinking, and hydromyelia.
- Some drugs also induced branchyury or anury, with or without lumbar myeloaplasia.
Conclusions:
- Neurotropic drugs possess teratogenic potential for the embryonic CNS, especially when administered during neural tube closure.
- The specific pattern and location of malformations may be influenced by the pharmacological properties of the neurotropic agents.
- Further research is needed to confirm these provisional findings and elucidate drug-specific teratogenic mechanisms.
More Related Videos
10:49Murine Neural Plate Targeting by In Utero Nano-Injection NEPTUNE at Embryonic Day 7.5
Published on: February 14, 2022
09:39Establishing Mouse Models for Zika Virus-induced Neurological Disorders Using Intracerebral Injection Strategies: Embryonic, Neonatal, and Adult
Published on: April 26, 2018